Vestal Point Capital, LP Uro Gen Pharma Ltd. Transaction History
Vestal Point Capital, LP
- $1.69 Trillion
- Q4 2024
A detailed history of Vestal Point Capital, LP transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,630,000 shares of URGN stock, worth $17.6 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
1,630,000
Previous 400,000
307.5%
Holding current value
$17.6 Million
Previous $5.08 Billion
241.72%
% of portfolio
1.03%
Previous 0.39%
Shares
2 transactions
Others Institutions Holding URGN
# of Institutions
138Shares Held
39.1MCall Options Held
9.8KPut Options Held
49.2K-
Rtw Investments, LP New York, NY3.83MShares$41.3 Million0.67% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA2.93MShares$31.5 Million0.06% of portfolio
-
Menora Mivtachim Holdings Ltd.2.3MShares$24.8 Million0.15% of portfolio
-
Black Rock Inc. New York, NY2.19MShares$23.6 Million0.0% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A61.75MShares$18.8 Million0.03% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $245M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...